Eggshell Membrane Market: Global Industry Research Report 2020-2027 | Envisage Research

Eggshell Membrane Market - By Type Insights (Hydrolysed, Unhydrolyzed), By Application (Pharmaceutical, Personal Care & Cosmetics, Food & Beverages, Nutraceuticals, Others) And By Region (North America, Asia Pacific, Europe, Middle East & Africa and Latin America) - Industry Analysis, Opportunity and Forecast 2020 To 2027

Published Date: May 2021

No. of Pages: 181

Status: Published

Report Code: EMR100469

The global eggshell membrane market size was valued at USD 102.2 million in 2020 and is expected to reach USD 174.5 million by 2027 at a CAGR of 7.7 %.Growing health awareness and changes in consumption habits are stimulating the growth of the global market. Eggshell membrane is one of the high-potential ingredients that is gaining widespread recognition across numerous end-use segments. The trend of using the product for supplementation has been around for a while, which further involves its usage in dermatological, cosmetic, and nutraceutical products. It was primarily perceived as a natural elixir to treat arthritis, which marked its entry into the pharmaceutical industry. Currently, the eggshell membrane is majorly utilized in a wide range of products with umpteen therapeutic advantages.



The U.S. has become one of the prominent countries in the industry owing to the high disposable income of consumers and the increasing need for nutritious food supplements. In addition, the market in the U.S. is projected to exhibit significant growth on account of the rapid development of the pharmaceutical industries and the presence of key manufacturers in the country.

Eggshell membrane, a thin film lining the inside of the calcified eggshell, is a novel dietary supplement that constitutes of naturally occurring proteins. This membrane serves as a protection against bacteria. It is a known source of calcium, which improves bone density and also contains important constituents needed for a stronger body, such as fibrous proteins like collagen Type 1, hyaluronic acid, bioactive elements, and chondroitin among many others.



The reason behind the high adoption of this product is not only its natural presence but also its properties, like high levels of hyaluronic acid, elastin, and keratin. These are favourable for hair and skin, bringing in the critical element of hydration and elasticity and also prove to be great for promoting joint health as they are a source of dietary calcium, enzymes, proteins, and acids.



Eggshell membrane powder is also considered to be one of the most beneficial ingredients to control aging, which further increases its penetration in the personal care and cosmetics industry. Moreover, the product is used to meet the essential skin and joint health requirements of the pet food industry and fulfill the nutritional needs of the pet.



Some prominent players in the global eggshell membrane market include: Stratum Nutrition (U.S.), Biova LLC (U.S.), Microcore Research Laboratories (India), Ecovatec Solutions (Canada), Eggnovo SL (Spain), Kewpie Corporation (Japan), Eggbrane (Netherlands), Certified Nutraceuticals Inc. (U.S.), Bolise Co., Limited (China), Mitushi Biopharma (India).



Analyst Commentary



The food and beverages application segment led the market and accounted for 35.18% share of the global revenue in 2020 on account of the product being touted as a high-potential element in dietary supplements and functional foods due to its capacity to condition and promote joint health.



The usage of the product as a source of dietary calcium across the food and beverage application is gaining considerable momentum since the food and beverage manufacturers have been directing their investments to a naturally-sourced component that assures high value in return.



The increasing application in cosmetic and nutraceutical products has resulted in increased skin nourishment and prevention of human joint health-related diseases, which is likely to be a significant factor in promoting the demand. However, numerous functionalities in industries, such as pharmaceutical and food and beverage, support the treatment of calcium deficiency and connective tissue and joint disorder issues, which eventually contributes to the total demand.



As per the researchers, natural eggshell membrane helps in treating the symptoms of osteoarthritis, thus offering a cost-effective alternative to glucosamine and chondroitin sulphate. The safety profile for eggshell membrane supplementation is gaining prominence in the nutraceutical application as no known side effects have been observed, apart from the certain egg allergy concern.



Hydrolysed egg membrane led the market and accounted for more than 72.0% share of the global revenue in 2020 on account of major factors, such as its concentration, mass availability, and content of membrane. Additionally, the presence of significant producers producing the ingredient in the hydrolysed form is boosting the segment growth.



Hydrolysed membranes are frequently used by an array of industries across the globe as they comprise the highest content of membrane. The hydrolysed eggshell membrane consists of a number of bioactive elements that impact the physiology and presentation of the skin, nails, or hair. The supply and demand sides both observed a high preference for the hydrolysed type, owing to which the hydrolysed segment is expected to dominate the industry over the forecast period.

However, governments are taking actions to process and limit the daily consumption of the hydrolysed type since it may lead to numerous human health-related issues and side effects owing to the synthetic chemicals used throughout its extraction. Hence, producers are showing an increased preference for the unhydrolyzed type as a component in their line of products to cater to the shifting demand.



Segmentation



The Eggshell membrane market is segmented on the basis of type insights, application and region. On the basis of type insights, the market is segmented into Hydrolysed, Unhydrolyzed. On the basis of application, the market is segmented into Pharmaceutical Personal Care & Cosmetics, Food & Beverages, Nutraceuticals, Others.



Regional Analysis



North America dominated the market and accounted for 34.70% share of the global revenue in 2020. Consumers in North America are highly health conscious than in other regions. Thus, increased demand for nutritious and healthy food supplements and high consumer affordability makes North America one of the significant regions in the global egg membrane industry.



The industry in Asia Pacific is expected to witness significant growth in the years to come on account of the growing concentration of eggshell membrane producing companies in the region. Additionally, the manufacturing of eggs remains the largest across the globe, resulting in lesser cost for procuring raw materials to extract the membrane.



Therefore, the development of technologies and the necessity of abundant raw materials have led producers in Asia Pacific to manufacture and supply eggshell membranes to numerous industries at a competitive price and gain benefits over their competitors in other regions, such as North America and Europe.



Furthermore, the rising awareness concerning the benefits of the product in nutraceutical, cosmetic and personal care, and food and beverage applications is expected to drive the demand for eggshell membrane, resulting in significant exports from the surplus manufacturing of eggshell membranes in the Asia Pacific region.



TABLE OF CONTENTS
Chapter 1. Executive Summary
Chapter 2. Research Methodology
2.1. Research approach
2.2. Scope, definition, and assumptions
2.3. Data sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary data mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key trends
3.2.1. xx
3.3. Market drivers
3.3.1. Impact analysis of Market Drivers
3.4. Market restraints
3.4.1. Impact analysis of Market Restraints
3.5. Market opportunities
3.5.1. Impact analysis of Market Opportunities
3.6. Market Challenges
3.6.1. Impact analysis of Market Trends
3.7. Porter’s Five Forces’ analysis
3.7.1. Bargaining Power of Suppliers
3.7.2. Bargaining Power of Buyers
3.7.3. Threat of New Entrant
3.7.4. Threat of Substitutes
3.7.5. High Competitive Rivalry
3.8. Value chain analysis
Chapter 4. COVID-19 Impact On Drug Discovery Services Market
Chapter 5. Global Drug Discovery Services Market Overview, By Process, 2015 – 2027 (USD Million)
5.1. Global Drug Discovery Services Market Share, By Process, 2020 & 2027 (%)
5.1.1. Target Selection
5.1.1.1. Market Size and Projections,2015 – 2027 (USD Million)
5.1.1.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
5.1.2. Target Validation
5.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.2.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
5.1.3. Hit-To-Lead Identification
5.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.3.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
5.1.4. Lead Optimization
5.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.4.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
5.1.5. Candidate Validation
5.1.5.1. Market Size and Projections, 2015 - 2027 (USD Million)
5.1.5.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
Chapter 6. Global Drug Discovery Services Market Overview, By Type, 2015 – 2027 (USD Million)
6.1. Global Drug Discovery Services Market Share, By Type, 2020 & 2027 (%)
6.1.1. Medicinal Chemistry
6.1.1.1. Market Size and Projections,2015 – 2027 (USD Million)
6.1.1.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.2. Biology Services
6.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.2.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.3. Drug Metabolism
6.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.3.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.4. Pharmaceutical Services
6.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.4.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
6.1.5. Pharmacokinetics
6.1.5.1. Market Size and Projections, 2015 - 2027 (USD Million)
6.1.5.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
Chapter 7. Global Drug Discovery Services Market Overview, By Therapeutic Area, 2015 – 2027 (USD Million)
7.1. Global Drug Discovery Services Market Share, By Therapeutic Area, 2020 & 2027 (%)
7.1.1. Oncology
7.1.1.1. Market Size and Projections,2015 – 2027 (USD Million)
7.1.1.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
7.1.2. Neurology
7.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.2.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
7.1.3. Cardiovascular Disease
7.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.3.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
7.1.4. Respiratory Disease
7.1.4.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.4.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
7.1.5. Diabetes
7.1.5.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.5.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
7.1.6. Others
7.1.6.1. Market Size and Projections, 2015 - 2027 (USD Million)
7.1.6.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
Chapter 8. Global Drug Discovery Services Market Overview, By Company Type, 2015 – 2027 (USD Million)
8.1. Global Drug Discovery Services Market Share, By Company Type, 2020 & 2027 (%)
8.1.1. Tier 1 Pharmaceutical Companies
8.1.1.1. Market Size and Projections,2015 – 2027 (USD Million)
8.1.1.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
8.1.2. Tier 2 Pharmaceutical Companies
8.1.2.1. Market Size and Projections, 2015 - 2027 (USD Million)
8.1.2.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
8.1.3. Tier 3 Pharmaceutical Companies
8.1.3.1. Market Size and Projections, 2015 - 2027 (USD Million)
8.1.3.2. Market Size and Projections, by Region, 2015 - 2027(USD Million)
Chapter 9. Global Aircraft Airframe MRO Market Overview, By Geography, 2015 - 2027 (USD Million)
9.1. Global Aircraft Airframe MRO Market Share, By Geography, 2015 - 2027(USD Million)
9.1.1. Market Size and projections, by Countries, 2015 - 2027 (USD Million)
9.1.2. Market Share and CAGR Comparison, by Countries, 2020 (%)
Chapter 10. North America Drug Discovery Services Market Overview, By Countries, 2015 - 2027(USD Million)
10.1. North America Drug Discovery Services Market Overview, 2020 & 2027 (%)
10.1.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.2. North America Drug Discovery Services Market Overview, By Process, 2015 - 2027(USD Million)
10.1.3. North America Drug Discovery Services Market Overview, By Type, 2015 - 2027(USD Million)
10.1.4. North America Drug Discovery Services Market Overview, By Therapeutic Area, 2015 - 2027(USD Million)
10.1.5. North America Drug Discovery Services Market Overview, By Company Type, 2015 - 2027(USD Million)
10.1.6. North America Drug Discovery Services Market Overview, By Countries, 2015 - 2027 (USD Million)
10.1.6.1. U.S. Drug Discovery Services Market Overview, 2015 - 2027 (USD Million)
10.1.6.1.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.6.1.2. U.S. Drug Discovery Services Market Overview, By Process, 2015 - 2027 (USD Million)
10.1.6.1.3. U.S. Drug Discovery Services Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.6.1.4. U.S. Drug Discovery Services Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
10.1.6.1.5. U.S. Drug Discovery Services Market Overview, By Company Type, 2015 - 2027 (USD Million)
10.1.6.2. Canada Drug Discovery Services Market Overview, 2015 - 2027 (USD Million)
10.1.6.2.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.6.2.2. Canada Drug Discovery Services Market Overview, By Process, 2015 - 2027 (USD Million)
10.1.6.2.3. Canada Drug Discovery Services Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.6.2.4. Canada Drug Discovery Services Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
10.1.6.2.5. Canada Drug Discovery Services Market Overview, By Company Type, 2015 - 2027 (USD Million)
10.1.6.3. Mexico Drug Discovery Services Market Overview, 2015 - 2027 (USD Million)
10.1.6.3.1. Market size and projections, 2015 - 2027 (USD Million)
10.1.6.3.2. Mexico Drug Discovery Services Market Overview, By Process, 2015 - 2027 (USD Million)
10.1.6.3.3. Mexico Drug Discovery Services Market Overview, By Type, 2015 - 2027 (USD Million)
10.1.6.3.4. Mexico Drug Discovery Services Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
10.1.6.3.5. Mexico Drug Discovery Services Market Overview, By Company Type, 2015 - 2027 (USD Million)
Chapter 11. Europe Drug Discovery Services Market Overview, By Countries, 2015 - 2027(USD Million)
11.1. Europe Drug Discovery Services Market Overview, 2020 & 2027 (%)
11.1.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.2. Europe Drug Discovery Services Market Overview, By Process, 2015 - 2027 (USD Million)
11.1.3. Europe Drug Discovery Services Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.4. Europe Drug Discovery Services Market Overview, By Therapeutic Area, 2015 - 2027 (USD Million)
11.1.5. Europe Drug Discovery Services Market Overview, By Company Type, 2015 - 2027 (USD Million)
11.1.6. Europe Drug Discovery Services Market Overview, By Countries, 2015 - 2027 (USD Million)
11.1.6.1. Germany
11.1.6.1.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.6.1.2. Germany Drug Discovery Services Market Overview, By Process, 2015 - 2027(USD Million)
11.1.6.1.3. Germany Drug Discovery Services Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.6.1.4. Germany Drug Discovery Services Market Overview, By Therapeutic Area, 2015 - 2027(USD Million)
11.1.6.1.5. Germany Drug Discovery Services Market Overview, By Company Type, 2015 - 2027(USD Million)
11.1.6.1.6. Market size and projections, 2015 - 2027 (USD Million)
11.1.6.1.7. France Drug Discovery Services Market Overview, By Process, 2015 - 2027(USD Million)
11.1.6.1.8. France Drug Discovery Services Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.6.1.9. France Drug Discovery Services Market Overview, By Therapeutic Area, 2015 - 2027(USD Million)
11.1.6.1.10. France Drug Discovery Services Market Overview, By Company Type, 2015 - 2027(USD Million)
11.1.6.2. UK
11.1.6.2.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.6.2.2. UK Drug Discovery Services Market Overview, By Process, 2015 - 2027(USD Million)
11.1.6.2.3. UK Drug Discovery Services Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.6.2.4. UK Drug Discovery Services Market Overview, By Therapeutic Area, 2015 - 2027(USD Million)
11.1.6.2.5. UK Drug Discovery Services Market Overview, By Company Type, 2015 - 2027(USD Million)
11.1.6.3. Italy
11.1.6.3.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.6.3.2. Italy Drug Discovery Services Market Overview, By Process, 2015 - 2027(USD Million)
11.1.6.3.3. Italy Drug Discovery Services Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.6.3.4. Italy Drug Discovery Services Market Overview, By Therapeutic Area, 2015 - 2027(USD Million)
11.1.6.3.5. Italy Drug Discovery Services Market Overview, By Company Type, 2015 - 2027(USD Million)
11.1.6.4. Spain
11.1.6.4.1. Market size and projections, 2015 - 2027 (USD Million)
11.1.6.4.2. Spain Drug Discovery Services Market Overview, By Process, 2015 - 2027(USD Million)
11.1.6.4.3. Spain Drug Discovery Services Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.6.4.4. Spain Drug Discovery Services Market Overview, By Therapeutic Area, 2015 - 2027(USD Million)
11.1.6.4.5. Spain Drug Discovery Services Market Overview, By Company Type, 2015 - 2027(USD Million)
11.1.6.5. Rest of Europe
11.1.6.5.1. Market size and projections, 2015 – 2025
11.1.6.5.2. Rest of Europe Drug Discovery Services Market Overview, By Process, 2015 - 2027(USD Million)
11.1.6.5.3. Rest of Europe Drug Discovery Services Market Overview, By Type, 2015 - 2027 (USD Million)
11.1.6.5.4. Rest of Europe Drug Discovery Services Market Overview, By Therapeutic Area, 2015 - 2027(USD Million)
11.1.6.5.5. Rest of Europe Drug Discovery Services Market Overview, By Company Type, 2015 - 2027(USD Million)
Chapter 12. Asia Pacific Drug Discovery Services Market Overview, By Countries, 2015 - 2027(USD Million)
12.1. Asia Pacific Drug Discovery Services Market Overview, 2020 & 2027(%)
12.1.1. Market size and projections, 2015 - 2027(USD Million)
12.1.2. Asia Pacific Drug Discovery Services Market Overview, By Process, 2015 - 2027(USD Million)
12.1.3. Asia Pacific Drug Discovery Services Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.4. Asia Pacific Drug Discovery Services Market Overview, By Therapeutic Area, 2015 - 2027(USD Million)
12.1.5. Asia Pacific Drug Discovery Services Market Overview, By Company Type, 2015 - 2027(USD Million)
12.1.6. Asia Pacific Drug Discovery Services Market Overview, By Countries, 2015 - 2027(USD Million)
12.1.6.1. India
12.1.6.1.1. Market size and projections, 2015 - 2027(USD Million)
12.1.6.1.2. India Drug Discovery Services Market Overview, By Process, 2015 - 2027(USD Million)
12.1.6.1.3. India Drug Discovery Services Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.6.1.4. India Drug Discovery Services Market Overview, By Therapeutic Area, 2015 - 2027(USD Million)
12.1.6.1.5. India Drug Discovery Services Market Overview, By Company Type, 2015 - 2027(USD Million)
12.1.6.2. China
12.1.6.2.1. Market size and projections, 2015 - 2027(USD Million)
12.1.6.2.2. China Drug Discovery Services Market Overview, By Process, 2015 - 2027(USD Million)
12.1.6.2.3. China Drug Discovery Services Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.6.2.4. China Drug Discovery Services Market Overview, By Therapeutic Area, 2015 - 2027(USD Million)
12.1.6.2.5. China Drug Discovery Services Market Overview, By Company Type, 2015 - 2027(USD Million)
12.1.6.3. Japan
12.1.6.3.1. Market size and projections, 2015 - 2027(USD Million)
12.1.6.3.2. Japan Drug Discovery Services Market Overview, By Process, 2015 - 2027(USD Million)
12.1.6.3.3. Japan Drug Discovery Services Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.6.3.4. Japan Drug Discovery Services Market Overview, By Therapeutic Area, 2015 - 2027(USD Million)
12.1.6.3.5. Japan Drug Discovery Services Market Overview, By Company Type, 2015 - 2027(USD Million)
12.1.6.4. South Korea
12.1.6.4.1. Market size and projections, 2015 - 2027(USD Million)
12.1.6.4.2. South Korea Drug Discovery Services Market Overview, By Process, 2015 - 2027(USD Million)
12.1.6.4.3. South Korea Drug Discovery Services Market Overview, By Type, 2015 - 2027 (USD Million)
12.1.6.4.4. South Korea Drug Discovery Services Market Overview, By Therapeutic Area, 2015 - 2027(USD Million)
12.1.6.4.5. South Korea Drug Discovery Services Market Overview, By Company Type, 2015 - 2027(USD Million)
12.1.6.5. Rest of Asia Pacific
12.1.6.5.1. Market size and projections, 2015 - 2027(USD Million)
12.1.6.5.2. Rest of Asia Pacific Drug Discovery Services Market Overview, By Process, 2015 - 2027(USD Million)
12.1.6.5.3. Rest of Asia Pacific Drug Discovery Services Market Overview, By Type, 2015 - 2027(USD Million)
12.1.6.5.4. Rest of Asia Pacific Drug Discovery Services Market Overview, By Therapeutic Area, 2015 - 2027(USD Million)
12.1.6.5.5. Rest of Asia Pacific Drug Discovery Services Market Overview, By Company Type, 2015 - 2027(USD Million)
Chapter 13. Middle East & Africa Drug Discovery Services Market Overview, By Countries, 2015 - 2027(USD Million)
13.1. Middle East & Africa Drug Discovery Services Market Overview, 2015 - 2027(USD Million)
13.1.1. Market size and projections, 2015 - 2027(USD Million)
13.1.2. Middle East & Africa Drug Discovery Services Market Overview, By Process, 2015 - 2027(USD Million)
13.1.3. Middle East & Africa Drug Discovery Services Market Overview, By Type, 2015 - 2027(USD Million)
13.1.4. Middle East & Africa Drug Discovery Services Market Overview, By Therapeutic Area, 2015 - 2027(USD Million)
13.1.5. Middle East & Africa Drug Discovery Services Market Overview, By Company Type, 2015 - 2027(USD Million)
13.1.6. Middle East & Africa Drug Discovery Services Market Overview, By Countries, 2015 - 2027(USD Million)
13.1.6.1. GCC
13.1.6.1.1. Market size and projections, 2015 - 2027(USD Million)
13.1.6.1.2. GCC Drug Discovery Services Market Overview, By Process, 2015 - 2027(USD Million)
13.1.6.1.3. GCC Drug Discovery Services Market Overview, By Type, 2015 - 2027(USD Million)
13.1.6.1.4. GCC Drug Discovery Services Market Overview, By Therapeutic Area, 2015 - 2027(USD Million)
13.1.6.1.5. GCC Drug Discovery Services Market Overview, By Company Type, 2015 - 2027(USD Million)
13.1.6.2. South Africa
13.1.6.2.1. Market size and projections, 2015 - 2027(USD Million)
13.1.6.2.2. South Africa Drug Discovery Services Market Overview, By Process, 2015 - 2027(USD Million)
13.1.6.2.3. South Africa Drug Discovery Services Market Overview, By Type, 2015 - 2027(USD Million)
13.1.6.2.4. South Africa Drug Discovery Services Market Overview, By Therapeutic Area, 2015 - 2027(USD Million)
13.1.6.2.5. South Africa Drug Discovery Services Market Overview, By Company Type, 2015 - 2027(USD Million)
13.1.6.3. Rest of Middle East & Africa
13.1.6.3.1. Market size and projections, 2015 - 2027(USD Million)
13.1.6.3.2. Rest of Middle East & Africa Drug Discovery Services Market Overview, By Process, 2015 - 2027(USD Million)
13.1.6.3.3. Rest of Middle East & Africa Drug Discovery Services Market Overview, By Type, 2015 - 2027(USD Million)
13.1.6.3.4. Rest of Middle East & Africa Drug Discovery Services Market Overview, By Therapeutic Area, 2015 - 2027(USD Million)
13.1.6.3.5. Rest of Middle East & Africa Drug Discovery Services Market Overview, By Company Type, 2015 - 2027(USD Million)
Chapter 14. South America Drug Discovery Services Market Overview, By Countries, 2015 - 2027(USD Million)
14.1. South America Drug Discovery Services Market Overview, 2015 - 2027(USD Million)
14.1.1. Market size and projections, 2015 - 2027(USD Million)
14.1.2. South America Drug Discovery Services Market Overview, By Process 2015 - 2027(USD Million)
14.1.3. South America Drug Discovery Services Market Overview, By Therapeutic Area 2015 - 2027(USD Million)
14.1.4. South America Drug Discovery Services Market Overview, By Type, 2015 - 2027(USD Million)
14.1.5. South America Drug Discovery Services Market Overview, By Company Type, 2015 - 2027(USD Million)
14.1.6. South America Drug Discovery Services Market Overview, By Countries, 2015- 2026(USD Million)
14.1.7. Brazil
14.1.7.1. Market size and projections, 2015 - 2027(USD Million)
14.1.7.2. Brazil Drug Discovery Services Market Overview, By Process, 2015 - 2027(USD Million)
14.1.7.3. Brazil Drug Discovery Services Market Overview, By Type, 2015 - 2027(USD Million)
14.1.7.4. Brazil Drug Discovery Services Market Overview, By Therapeutic Area, 2015 - 2027(USD Million)
14.1.7.5. Brazil Drug Discovery Services Market Overview, By Company Type, 2015 - 2027(USD Million)
14.1.8. Argentina
14.1.8.1. Market size and projections, 2015 - 2027(USD Million)
14.1.8.2. Argentina Drug Discovery Services Market Overview, By Process, 2015 - 2027(USD Million)
14.1.8.3. Argentina Drug Discovery Services Market Overview, By Type, 2015 - 2027(USD Million)
14.1.8.4. Argentina Drug Discovery Services Market Overview, By Therapeutic Area, 2015 - 2027(USD Million)
14.1.8.5. Argentina Drug Discovery Services Market Overview, By Company Type, 2015 - 2027(USD Million)
14.1.9. Rest of South America
14.1.9.1. Market size and projections, 2015 – 2026
14.1.9.2. Rest of South America Drug Discovery Services Market Overview, By Process, 2015 - 2027(USD Million)
14.1.9.3. Rest of South America Drug Discovery Services Market Overview, By Type, 2015 - 2027(USD Million)
14.1.9.4. Rest of South America Drug Discovery Services Market Overview, By Therapeutic Area, 2015 - 2027(USD Million)
14.1.9.5. Rest of South America Drug Discovery Services Market Overview, By Company Type, 2015 - 2027(USD Million)
Chapter 15. Competitive Landscape
15.1. Competitive environment, 2020
15.2. Strategic framework
15.2.1. Partnership/agreement
15.2.2. Expansion
15.2.3. Mergers & Acquisitions
15.2.4. New product development
Chapter 16. Key Vendor Analysis
16.1. Albany Molecular Research, Inc
16.1.1. Company overview
16.1.2. Financial performance
16.1.3. Product Benchmarking
16.1.4. Recent initiatives
16.1.5. SWOT analysis
16.2. Charles River Laboratories International, Inc
16.2.1. Company overview
16.2.2. Financial performance
16.2.3. Product Benchmarking
16.2.4. Recent initiatives
16.2.5. SWOT analysis
16.3. Evotec SE
16.4. Eurofins Scientific
16.5. WuXi AppTec
16.6. GenScript Biotech Corporation
16.7. Selvita S.A.
16.8. Syngene International Ltd
16.9. Selvita S.A.
Chapter 17. Drug Discovery Services Market Cost Analysis
17.1. Drug Discovery Services Market Key Raw Materials Analysis
17.1.1. Key Raw Materials
17.1.2. Price Trend of Key Raw Materials
17.1.3. Key Suppliers of Raw Materials
17.1.4. Market Concentration Rate of Raw Materials
17.2. Proportion of Isophthalic Resin Cost Structure
17.2.1. Raw Materials
17.2.2. Labor Cost
Chapter 18. Industrial Chain, Sourcing Strategy and Downstream Buyers
18.1. Drug Discovery Services Market Industrial Chain Analysis
18.2. Upstream Raw Materials Sourcing
18.3. Raw Materials Sources of Drug Discovery Services Market Major Manufacturers in 2020
18.4. Downstream Buyers
Chapter 19. Marketing Strategy Analysis, Distributors/Traders
19.1. Marketing Channel
19.1.1. Direct Marketing
19.1.2. Indirect Marketing
19.1.3. Marketing Channel Development Trend
19.2. Market Positioning
19.2.1. Pricing Strategy
19.2.2. Brand Strategy
19.2.3. Target Client
19.3. Distributors/Traders List
Chapter 20. Market Effect Factors Analysis
20.1. Technology Progress/Risk
20.1.1. Substitutes Threat
20.1.2. Technology Progress in Related Industry
20.2. Consumer Needs/Customer Preference Change
20.3. Economic/Political Environmental Change
Chapter 21. Future Outlook of the Market
Disclaimer

List of Figures
1. Market segmentation
2. Value chain analysis
3. Porter’s Five Forces’ analysis
4. Power of Suppliers
5. Power of Buyers
6. Threat of New Entrants
7. Threat of Substitute
8. Competitive Rivalry
9. Global Drug Discovery Services Market share, By Process, 2020 & 2027 (%)
10. Global Drug Discovery Services Market, by Target Selection, By Process, 2015 - 2027(USD Million)
11. Global Drug Discovery Services Market, by Target Validation, By Process 2015 - 2027(USD Million)
12. Global Drug Discovery Services Market, by Hit-To-Lead Identification, By Process 2015 - 2027(USD Million)
13. Global Drug Discovery Services Market, by Lead Optimization, By Process 2015 - 2027(USD Million)
14. Global Drug Discovery Services Market, by Candidate Validation, By Process 2015 - 2027(USD Million)
15. Global Drug Discovery Services Market share, By Type, 2020 & 2027 (%)
16. Global Drug Discovery Services Market, by Medicinal Chemistry, By Type, 2015 - 2027(USD Million)
17. Global Drug Discovery Services Market, by Biology Services, By Type, 2015 - 2027(USD Million)
18. Global Drug Discovery Services Market, by Drug Metabolism, By Type, 2015 - 2027(USD Million)
19. Global Drug Discovery Services Market, by Pharmaceutical Services, By Type, 2015 - 2027(USD Million)
20. Global Drug Discovery Services Market, by Pharmacokinetics, By Type, 2015 - 2027(USD Million)
21. Global Drug Discovery Services Market share, By Therapeutic Area, 2020 & 2027 (%)
22. Global Drug Discovery Services Market, by Oncology, By Therapeutic Area, 2015 - 2027(USD Million)
23. Global Drug Discovery Services Market, by Neurology, By Therapeutic Area, 2015 - 2027(USD Million)
24. Global Drug Discovery Services Market, by Cardiovascular Disease, By Therapeutic Area, 2015 - 2027(USD Million)
25. Global Drug Discovery Services Market, by Respiratory Disease, By Therapeutic Area, 2015 - 2027(USD Million)
26. Global Drug Discovery Services Market, by Diabetes, By Therapeutic Area, 2015 - 2027(USD Million)
27. Global Drug Discovery Services Market, by Others, By Therapeutic Area, 2015 - 2027(USD Million)
28. Global Drug Discovery Services Market share, by region, 2020 & 2027 (%)
29. North America Drug Discovery Services Market, 2020 - 2027(USD Million)
30. North America Drug Discovery Services Market share, by Countries, 2020 & 2027 (%)
31. U.S. Drug Discovery Services Market, 2020 - 2027(USD Million)
32. Canada Drug Discovery Services Market, 2020 - 2027(USD Million)
33. Europe Drug Discovery Services Market, 2020 - 2027(USD Million)
34. Europe Drug Discovery Services Market share, by Countries, 2020 & 2027 (%)
35. Spain Drug Discovery Services Market, 2020 - 2027(USD Million)
36. UK Drug Discovery Services Market, 2020 - 2027(USD Million)
37. Italy Drug Discovery Services Market, 2020 - 2027(USD Million)
38. Germany Drug Discovery Services Market, 2020 - 2027(USD Million)
39. France Drug Discovery Services Market, 2020 - 2027(USD Million)
40. Rest of Europe Drug Discovery Services Market, 2020 - 2027(USD Million)
41. Asia-Pacific Drug Discovery Services Market, 2020 - 2027(USD Million)
42. Asia-Pacific Drug Discovery Services Market share, by Countries, 2020 & 2027 (%)
43. China Drug Discovery Services Market, 2020 - 2027(USD Million)
44. India Drug Discovery Services Market, 2020 - 2027(USD Million)
45. Australia Drug Discovery Services Market, 2020 - 2027(USD Million)
46. Japan Drug Discovery Services Market, 2020 - 2027(USD Million)
47. Rest of Asia-Pacific Drug Discovery Services Market, 2020 - 2027(USD Million)
48. Middle East & Africa Drug Discovery Services Market, 2020 - 2027(USD Million)
49. Middle East & Africa Drug Discovery Services Market share, by Countries, 2020 & 2027 (%)
50. GCC Drug Discovery Services Market, 2020 - 2027(USD Million)
51. South Africa Drug Discovery Services Market, 2020 - 2027(USD Million)
52. Rest Of Middle East & Africa Drug Discovery Services Market, 2020 - 2027(USD Million)
53. South America Drug Discovery Services Market, 2020 - 2027(USD Million)
54. Brazil Drug Discovery Services Market, 2020 - 2027(USD Million)
55. Mexico Drug Discovery Services Market, 2020 - 2027(USD Million)
56. Argentina Drug Discovery Services Market, 2020 - 2027(USD Million)
57. Rest of South America Drug Discovery Services Market, 2020 - 2027(USD Million)
List of Tables
1. Impact of Market drivers
2. Impact of Market restraints
3. Global Drug Discovery Services Market, 2015-2027(USD Million)
4. Global Drug Discovery Services Market requirement, by country, 2015-2027,(USD Million)
5. North America Drug Discovery Services Market, By Process, 2015-2027(USD Million)
6. North America Drug Discovery Services Market, By Type, 2015-2027(USD Million)
7. North America Drug Discovery Services Market, By Therapeutic Area, 2015-2027(USD Million)
8. North America Drug Discovery Services Market, By Company Type, 2015-2027(USD Million)
9. Europe Drug Discovery Services Market, By Process, 2015-2027(USD Million)
10. Europe Drug Discovery Services Market, By Type, 2015-2027(USD Million)
11. Europe Drug Discovery Services Market, By Therapeutic Area, 2015-2027(USD Million)
12. Europe Drug Discovery Services Market, By Company Type, 2015-2027(USD Million)
13. Asia Pacific Drug Discovery Services Market, By Process, 2015-2027(USD Million)
14. Asia Pacific Drug Discovery Services Market, By Type, 2015-2027(USD Million)
15. Asia Pacific Drug Discovery Services Market, By Therapeutic Area, 2015-2027(USD Million)
16. Asia Pacific Drug Discovery Services Market, By Company Type, 2015-2027(USD Million)
17. Middle East & Africa Drug Discovery Services Market, By Process, 2015-2027(USD Million)
18. Middle East & Africa Drug Discovery Services Market, By Type, 2015-2027(USD Million)
19. Middle East & Africa Drug Discovery Services Market, By Therapeutic Area, 2015-2027(USD Million)
20. Middle East & Africa Drug Discovery Services Market, By Company Type, 2015-2027(USD Million)
21. South America Drug Discovery Services Market, By Process, 2015-2027(USD Million)
22. South America Drug Discovery Services Market, By Type, 2015-2027(USD Million)
23. South America Drug Discovery Services Market, By Therapeutic Area, 2015-2027(USD Million)
24. South America Drug Discovery Services Market, By Company Type, 2015-2027(USD Million)
25. Global Drug Discovery Services Market, Company Market Share, 2020 (%)
26. Albany Molecular Research, Inc: Product Benchmarking
27. Albany Molecular Research, Inc: Financial Performance
28. Charles River Laboratories International, Inc: Product Benchmarking
29. Charles River Laboratories International, Inc: Financial Performance
30. Evotec SE: Product Benchmarking
31. Evotec SE: Financial Performance
32. Eurofins Scientific: Product Benchmarking
33. Eurofins Scientific: Financial Performance
34. WuXi AppTec: Product Benchmarking
35. WuXi AppTec: Financial Performance
36. GenScript Biotech Corporation: Product Benchmarking
37. GenScript Biotech Corporation: Financial Performance
38. Selvita S.A.: Product Benchmarking
39. Selvita S.A.: Financial Performance
40. Syngene International Ltd: Product Benchmarking
41. Syngene International Ltd: Financial Performance
42. Selvita S.A.: Product Benchmarking
43. Selvita S.A.: Financial Performance

The Leading Key Players in Eggshell Membrane Market

Stratum Nutrition (U.S.)
Biova LLC (U.S.)
Microcore Research Laboratories (India)
Ecovatec Solutions (Canada)
Eggnovo SL (Spain)
Kewpie Corporation (Japan)
Eggbrane (Netherlands)
Certified Nutraceuticals Inc. (U.S.)
Bolise Co.
Limited (China)
Mitushi Biopharma (India).